Ardelyx reported $127.8M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Amgen USD 23.23B 2.27B Sep/2026
Ardelyx USD 127.8M 4.42M Sep/2026
aTyr Pharma USD 16.46M 5.07M Sep/2026
Corcept Therapeutics USD 177.68M 23.87M Sep/2026
Curis USD 14.97M 898K Mar/2026
Sanofi EUR 31.93B 1.92B Jun/2026
TG Therapeutics USD 260.53M 7.97M Sep/2026
United Therapeutics USD 624.3M 16.5M Sep/2026